BIOENGINEER

TRPM7 Channel Drives Heart Damage After Ischemia-Reperfusion Through a Newly Traced Molecular Pathway

A new study in mice and cardiomyocytes shows that TRPM7 promotes ischemia-reperfusion heart injury through a ...
Yahoo Finance

NLRP3 Protein Inhibitors Pipeline Research Report 2024: Therapeutic Assessment of 25+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "NLRP3 Protein Inhibitors - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering. The report provides comprehensive ...
Healio

NLRP3 inhibitor reduces inflammatory biomarkers in high-risk patients

Please provide your email address to receive an email when new articles are posted on . Ruvonoflast reduced high-sensitivity C-reactive protein and other inflammatory biomarkers at 28 days vs. placebo ...
newswise

Ultrasound-Responsive Renal-Targeted Nanoparticles Deliver TAK-242 to Inhibit NF-κB/NLRP3 Signaling and Attenuate Sepsis-Associated Acute Kidney Injury

Sepsis-associated acute kidney injury (SA-AKI) remains a major clinical challenge due to the lack of effective targeted therapies. In this study, we designed ultrasound-responsive, renal-targeted ...

Monte Rosa Therapeutics, Inc.: Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ...

In obese subjects at elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1-driven inflammatory diseases, normaliz ...
Yahoo Finance

NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight

DelveInsight's 'NLRP3 Protein Inhibitors Pipeline Insight 2024' report provides comprehensive global coverage of pipeline NLRP3 protein inhibitors in various stages of clinical development, major ...